Srinivas Ramachandran
Concepts (298)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Nucleosomes | 15 | 2025 | 156 | 3.660 |
Why?
| | Histones | 11 | 2025 | 641 | 3.000 |
Why?
| | Chromatin | 10 | 2025 | 536 | 2.100 |
Why?
| | Chromatin Assembly and Disassembly | 8 | 2025 | 103 | 1.880 |
Why?
| | Transcription, Genetic | 10 | 2022 | 1486 | 1.410 |
Why?
| | Transcription Factors | 6 | 2022 | 1706 | 1.390 |
Why?
| | Cell-Free Nucleic Acids | 2 | 2022 | 33 | 1.370 |
Why?
| | Promoter Regions, Genetic | 9 | 2025 | 1244 | 1.300 |
Why?
| | Computational Biology | 7 | 2025 | 663 | 1.210 |
Why?
| | Heterochromatin | 2 | 2025 | 54 | 1.070 |
Why?
| | Saccharomycetales | 2 | 2018 | 27 | 0.990 |
Why?
| | Histone Chaperones | 1 | 2025 | 15 | 0.910 |
Why?
| | Saccharomyces cerevisiae Proteins | 4 | 2025 | 403 | 0.900 |
Why?
| | G1 Phase | 1 | 2025 | 72 | 0.900 |
Why?
| | DNA Replication | 2 | 2017 | 237 | 0.880 |
Why?
| | Open Reading Frames | 1 | 2025 | 132 | 0.860 |
Why?
| | Drosophila melanogaster | 4 | 2019 | 234 | 0.820 |
Why?
| | Psoriasis | 1 | 2025 | 112 | 0.820 |
Why?
| | Polycomb Repressive Complex 2 | 1 | 2024 | 68 | 0.790 |
Why?
| | Cell Cycle | 2 | 2024 | 601 | 0.780 |
Why?
| | DNA | 2 | 2022 | 1440 | 0.760 |
Why?
| | Alzheimer Disease | 9 | 2025 | 600 | 0.740 |
Why?
| | Protein Binding | 8 | 2025 | 2233 | 0.700 |
Why?
| | Epigenomics | 2 | 2020 | 112 | 0.680 |
Why?
| | NF-kappa B | 1 | 2025 | 684 | 0.670 |
Why?
| | Oryza | 3 | 2020 | 29 | 0.670 |
Why?
| | DNA Methylation | 3 | 2022 | 643 | 0.660 |
Why?
| | Gene Expression Regulation | 5 | 2025 | 2600 | 0.650 |
Why?
| | Enhancer Elements, Genetic | 1 | 2021 | 189 | 0.620 |
Why?
| | Genome, Fungal | 3 | 2017 | 40 | 0.610 |
Why?
| | RNA Polymerase II | 6 | 2022 | 340 | 0.600 |
Why?
| | Deoxyuridine | 1 | 2018 | 6 | 0.560 |
Why?
| | Fungi | 2 | 2017 | 152 | 0.550 |
Why?
| | Software | 3 | 2025 | 675 | 0.530 |
Why?
| | Fungal Vaccines | 1 | 2017 | 1 | 0.520 |
Why?
| | Mycobacterium tuberculosis | 2 | 2019 | 318 | 0.510 |
Why?
| | Hydro-Lyases | 1 | 2016 | 6 | 0.510 |
Why?
| | Bridged-Ring Compounds | 1 | 2016 | 27 | 0.500 |
Why?
| | Mycoses | 1 | 2017 | 86 | 0.480 |
Why?
| | S Phase | 1 | 2016 | 77 | 0.480 |
Why?
| | Ketones | 1 | 2016 | 52 | 0.480 |
Why?
| | Epigenesis, Genetic | 2 | 2020 | 661 | 0.480 |
Why?
| | Methylation | 3 | 2025 | 231 | 0.470 |
Why?
| | Saccharomyces cerevisiae | 4 | 2025 | 556 | 0.470 |
Why?
| | Fomites | 1 | 2015 | 7 | 0.460 |
Why?
| | Drug Resistance, Microbial | 1 | 2015 | 67 | 0.450 |
Why?
| | Mutation | 7 | 2025 | 4006 | 0.450 |
Why?
| | Bacterial Proteins | 3 | 2019 | 913 | 0.440 |
Why?
| | Binding Sites | 7 | 2025 | 1311 | 0.440 |
Why?
| | Mouse Embryonic Stem Cells | 2 | 2025 | 31 | 0.440 |
Why?
| | Amyloid beta-Peptides | 5 | 2016 | 233 | 0.430 |
Why?
| | High-Throughput Nucleotide Sequencing | 1 | 2018 | 543 | 0.420 |
Why?
| | Micrococcal Nuclease | 3 | 2021 | 26 | 0.420 |
Why?
| | Databases, Genetic | 3 | 2025 | 244 | 0.420 |
Why?
| | Metagenomics | 1 | 2015 | 180 | 0.410 |
Why?
| | Gene Expression Profiling | 6 | 2022 | 1761 | 0.400 |
Why?
| | Phenotype | 2 | 2020 | 3172 | 0.370 |
Why?
| | Virulence Factors | 1 | 2014 | 162 | 0.370 |
Why?
| | Workflow | 2 | 2025 | 175 | 0.370 |
Why?
| | Animals | 17 | 2025 | 37328 | 0.370 |
Why?
| | Breast Neoplasms | 3 | 2025 | 2246 | 0.350 |
Why?
| | Gene Expression Regulation, Fungal | 2 | 2025 | 71 | 0.350 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2025 | 2529 | 0.320 |
Why?
| | Peptide Fragments | 5 | 2016 | 696 | 0.320 |
Why?
| | Amyloid beta-Protein Precursor | 2 | 2025 | 67 | 0.320 |
Why?
| | Estrogen Receptor alpha | 2 | 2025 | 145 | 0.320 |
Why?
| | Biomarkers | 1 | 2020 | 4180 | 0.300 |
Why?
| | Genomics | 3 | 2018 | 811 | 0.300 |
Why?
| | Superoxide Dismutase-1 | 2 | 2018 | 12 | 0.290 |
Why?
| | Chromatin Immunoprecipitation | 2 | 2020 | 136 | 0.270 |
Why?
| | Dinucleotide Repeats | 1 | 2007 | 5 | 0.270 |
Why?
| | Molecular Dynamics Simulation | 7 | 2019 | 247 | 0.260 |
Why?
| | Microbiota | 1 | 2015 | 753 | 0.260 |
Why?
| | Amyotrophic Lateral Sclerosis | 2 | 2018 | 98 | 0.260 |
Why?
| | Cell Differentiation | 2 | 2025 | 1983 | 0.260 |
Why?
| | Introns | 1 | 2007 | 253 | 0.240 |
Why?
| | Humans | 32 | 2025 | 141284 | 0.240 |
Why?
| | Drosophila | 3 | 2021 | 154 | 0.240 |
Why?
| | Genome, Plant | 3 | 2011 | 30 | 0.240 |
Why?
| | Cyclins | 1 | 2006 | 91 | 0.230 |
Why?
| | Evolution, Molecular | 2 | 2018 | 503 | 0.230 |
Why?
| | Presenilin-2 | 1 | 2025 | 6 | 0.230 |
Why?
| | Presenilin-1 | 1 | 2025 | 33 | 0.220 |
Why?
| | Cell Line | 3 | 2021 | 2863 | 0.220 |
Why?
| | Protein Domains | 2 | 2024 | 305 | 0.220 |
Why?
| | HEK293 Cells | 2 | 2025 | 738 | 0.220 |
Why?
| | Germ Cells | 1 | 2024 | 63 | 0.220 |
Why?
| | Enhancer of Zeste Homolog 2 Protein | 1 | 2024 | 54 | 0.220 |
Why?
| | Polycomb-Group Proteins | 1 | 2024 | 29 | 0.210 |
Why?
| | Embryonic Stem Cells | 1 | 2025 | 129 | 0.210 |
Why?
| | Protein Conformation | 5 | 2018 | 939 | 0.200 |
Why?
| | Lysine | 1 | 2025 | 292 | 0.190 |
Why?
| | Hepatocyte Nuclear Factor 3-alpha | 1 | 2022 | 8 | 0.190 |
Why?
| | DNA-Binding Proteins | 3 | 2022 | 1483 | 0.190 |
Why?
| | Hydrogen Bonding | 3 | 2018 | 168 | 0.190 |
Why?
| | Phylogeny | 2 | 2011 | 997 | 0.190 |
Why?
| | Molecular Docking Simulation | 3 | 2019 | 111 | 0.190 |
Why?
| | Transcriptional Elongation Factors | 1 | 2022 | 38 | 0.190 |
Why?
| | Gene Regulatory Networks | 1 | 2025 | 309 | 0.190 |
Why?
| | Methanococcus | 1 | 2002 | 8 | 0.180 |
Why?
| | Protein Processing, Post-Translational | 1 | 2024 | 462 | 0.180 |
Why?
| | Sorghum | 2 | 2011 | 2 | 0.180 |
Why?
| | Haemophilus influenzae | 1 | 2002 | 63 | 0.180 |
Why?
| | Estradiol | 1 | 2025 | 523 | 0.180 |
Why?
| | T-Lymphocytes, Regulatory | 1 | 2024 | 393 | 0.180 |
Why?
| | Membrane Proteins | 1 | 2007 | 1144 | 0.170 |
Why?
| | Arabs | 1 | 2021 | 8 | 0.170 |
Why?
| | User-Computer Interface | 2 | 2025 | 163 | 0.170 |
Why?
| | Protein Interaction Maps | 1 | 2021 | 49 | 0.170 |
Why?
| | Amyloid | 4 | 2016 | 96 | 0.170 |
Why?
| | Mice | 4 | 2025 | 17969 | 0.170 |
Why?
| | Altitude Sickness | 1 | 2022 | 150 | 0.170 |
Why?
| | Cyclin-Dependent Kinase 9 | 1 | 2020 | 18 | 0.170 |
Why?
| | Induced Pluripotent Stem Cells | 1 | 2023 | 265 | 0.160 |
Why?
| | Histone Demethylases | 1 | 2020 | 31 | 0.160 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 4 | 2020 | 983 | 0.160 |
Why?
| | Gene Expression | 2 | 2020 | 1490 | 0.160 |
Why?
| | Lipid Bilayers | 3 | 2016 | 102 | 0.160 |
Why?
| | Peptide Synthases | 1 | 2019 | 3 | 0.160 |
Why?
| | Receptors, Estrogen | 1 | 2022 | 412 | 0.150 |
Why?
| | Cytochrome P-450 Enzyme System | 1 | 2020 | 157 | 0.150 |
Why?
| | Drug Evaluation, Preclinical | 1 | 2019 | 191 | 0.150 |
Why?
| | Transcriptional Activation | 1 | 2021 | 377 | 0.150 |
Why?
| | Small Molecule Libraries | 1 | 2019 | 99 | 0.150 |
Why?
| | Genetic Predisposition to Disease | 2 | 2025 | 2366 | 0.140 |
Why?
| | Genome | 1 | 2021 | 303 | 0.140 |
Why?
| | Biosensing Techniques | 1 | 2020 | 138 | 0.140 |
Why?
| | Models, Molecular | 4 | 2018 | 1602 | 0.140 |
Why?
| | Chromosome Mapping | 3 | 2011 | 502 | 0.140 |
Why?
| | Quantitative Trait Loci | 1 | 2020 | 364 | 0.140 |
Why?
| | Antitubercular Agents | 1 | 2019 | 203 | 0.140 |
Why?
| | Transcription Initiation Site | 1 | 2017 | 42 | 0.140 |
Why?
| | Alleles | 1 | 2021 | 878 | 0.140 |
Why?
| | TATA-Box Binding Protein | 1 | 2017 | 20 | 0.140 |
Why?
| | Oligopeptides | 1 | 2019 | 264 | 0.130 |
Why?
| | Fluorescent Dyes | 1 | 2019 | 321 | 0.130 |
Why?
| | Click Chemistry | 1 | 2018 | 50 | 0.130 |
Why?
| | Clinical Decision-Making | 1 | 2020 | 341 | 0.130 |
Why?
| | Epitopes, B-Lymphocyte | 1 | 2017 | 17 | 0.130 |
Why?
| | Antigens, Fungal | 1 | 2017 | 27 | 0.130 |
Why?
| | Sequence Analysis, DNA | 2 | 2015 | 815 | 0.130 |
Why?
| | Gene Duplication | 2 | 2007 | 65 | 0.130 |
Why?
| | Enzyme Inhibitors | 2 | 2019 | 835 | 0.130 |
Why?
| | Glioblastoma | 1 | 2020 | 344 | 0.120 |
Why?
| | Inhibitory Concentration 50 | 1 | 2016 | 91 | 0.120 |
Why?
| | Eukaryota | 1 | 2017 | 60 | 0.120 |
Why?
| | Aspartic Acid | 1 | 2016 | 81 | 0.120 |
Why?
| | Pyruvic Acid | 1 | 2016 | 55 | 0.120 |
Why?
| | SELEX Aptamer Technique | 1 | 2016 | 16 | 0.120 |
Why?
| | Disease Management | 1 | 2020 | 634 | 0.120 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2022 | 1439 | 0.120 |
Why?
| | Epilepsy | 1 | 2020 | 359 | 0.120 |
Why?
| | Gene Expression Regulation, Plant | 3 | 2020 | 53 | 0.120 |
Why?
| | Drosophila Proteins | 1 | 2017 | 205 | 0.120 |
Why?
| | Response Elements | 1 | 2016 | 89 | 0.120 |
Why?
| | Epitopes, T-Lymphocyte | 1 | 2017 | 181 | 0.120 |
Why?
| | Catalytic Domain | 1 | 2016 | 223 | 0.120 |
Why?
| | tau Proteins | 1 | 2016 | 96 | 0.110 |
Why?
| | Ion Channels | 1 | 2016 | 128 | 0.110 |
Why?
| | Prognosis | 2 | 2020 | 4080 | 0.110 |
Why?
| | Aptamers, Nucleotide | 1 | 2016 | 85 | 0.110 |
Why?
| | Trans-Activators | 1 | 2017 | 395 | 0.110 |
Why?
| | Crystallography, X-Ray | 1 | 2016 | 485 | 0.110 |
Why?
| | India | 1 | 2015 | 210 | 0.110 |
Why?
| | Enzyme Activation | 1 | 2016 | 784 | 0.110 |
Why?
| | Metabolomics | 1 | 2020 | 702 | 0.110 |
Why?
| | Recombinant Proteins | 2 | 2016 | 1362 | 0.110 |
Why?
| | Plasmodium | 1 | 2014 | 11 | 0.110 |
Why?
| | DNA, Fungal | 1 | 2014 | 79 | 0.100 |
Why?
| | DNA-Directed RNA Polymerases | 1 | 2014 | 63 | 0.100 |
Why?
| | Adhesins, Bacterial | 1 | 2014 | 40 | 0.100 |
Why?
| | Centromere | 1 | 2014 | 59 | 0.100 |
Why?
| | Carrier Proteins | 1 | 2017 | 738 | 0.100 |
Why?
| | Microtubules | 1 | 2016 | 282 | 0.100 |
Why?
| | Allergens | 1 | 2017 | 399 | 0.100 |
Why?
| | Chromosomal Proteins, Non-Histone | 1 | 2014 | 125 | 0.100 |
Why?
| | Models, Biological | 3 | 2018 | 1810 | 0.100 |
Why?
| | Malaria | 1 | 2014 | 66 | 0.100 |
Why?
| | Sequence Deletion | 1 | 2013 | 183 | 0.100 |
Why?
| | Kinetics | 1 | 2016 | 1620 | 0.100 |
Why?
| | MicroRNAs | 1 | 2019 | 693 | 0.100 |
Why?
| | Genetic Variation | 2 | 2021 | 993 | 0.090 |
Why?
| | Drug Discovery | 1 | 2013 | 146 | 0.090 |
Why?
| | Edible Grain | 1 | 2011 | 47 | 0.090 |
Why?
| | Signal Transduction | 1 | 2025 | 5116 | 0.090 |
Why?
| | Basic-Leucine Zipper Transcription Factors | 1 | 2011 | 40 | 0.080 |
Why?
| | Brain Neoplasms | 1 | 2020 | 1282 | 0.080 |
Why?
| | Phosphorylation | 3 | 2022 | 1753 | 0.080 |
Why?
| | Protein Structure, Secondary | 3 | 2018 | 368 | 0.080 |
Why?
| | Host-Pathogen Interactions | 1 | 2014 | 369 | 0.080 |
Why?
| | Cells, Cultured | 1 | 2017 | 4149 | 0.080 |
Why?
| | Structure-Activity Relationship | 3 | 2018 | 569 | 0.080 |
Why?
| | Protein Structure, Tertiary | 2 | 2010 | 858 | 0.070 |
Why?
| | Expressed Sequence Tags | 1 | 2007 | 42 | 0.070 |
Why?
| | Bacteria | 1 | 2014 | 872 | 0.060 |
Why?
| | DNA Primers | 1 | 2007 | 507 | 0.060 |
Why?
| | Disasters | 1 | 2007 | 99 | 0.060 |
Why?
| | Microsatellite Repeats | 1 | 2007 | 158 | 0.060 |
Why?
| | Chromosomes, Artificial, Bacterial | 1 | 2006 | 19 | 0.060 |
Why?
| | DNA Copy Number Variations | 2 | 2020 | 178 | 0.060 |
Why?
| | Algorithms | 1 | 2014 | 1764 | 0.060 |
Why?
| | Ribosomes | 1 | 2007 | 187 | 0.060 |
Why?
| | Genetic Markers | 2 | 2020 | 343 | 0.060 |
Why?
| | Hydrophobic and Hydrophilic Interactions | 2 | 2018 | 188 | 0.060 |
Why?
| | Multigene Family | 1 | 2006 | 202 | 0.060 |
Why?
| | Arabidopsis Proteins | 1 | 2006 | 72 | 0.060 |
Why?
| | Neurons | 2 | 2025 | 1611 | 0.060 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2007 | 757 | 0.060 |
Why?
| | STAT1 Transcription Factor | 1 | 2025 | 71 | 0.060 |
Why?
| | MCF-7 Cells | 1 | 2025 | 127 | 0.060 |
Why?
| | Genome, Human | 1 | 2007 | 420 | 0.060 |
Why?
| | CD28 Antigens | 1 | 2024 | 57 | 0.050 |
Why?
| | Models, Genetic | 1 | 2007 | 587 | 0.050 |
Why?
| | Amino Acid Sequence | 3 | 2016 | 2146 | 0.050 |
Why?
| | Base Sequence | 3 | 2016 | 2170 | 0.050 |
Why?
| | Down Syndrome | 1 | 2010 | 504 | 0.050 |
Why?
| | Strongyloides stercoralis | 1 | 2002 | 2 | 0.050 |
Why?
| | Antigens, Helminth | 1 | 2002 | 15 | 0.050 |
Why?
| | Strongyloidiasis | 1 | 2002 | 4 | 0.050 |
Why?
| | Peptide Elongation Factors | 1 | 2022 | 15 | 0.050 |
Why?
| | Microscopy, Atomic Force | 2 | 2016 | 129 | 0.050 |
Why?
| | Female | 4 | 2025 | 75814 | 0.050 |
Why?
| | Erythropoiesis | 1 | 2022 | 56 | 0.050 |
Why?
| | Genome, Archaeal | 1 | 2002 | 12 | 0.050 |
Why?
| | Cell Line, Tumor | 2 | 2020 | 3502 | 0.050 |
Why?
| | Archaeal Proteins | 1 | 2002 | 45 | 0.040 |
Why?
| | Familial Mediterranean Fever | 1 | 2021 | 8 | 0.040 |
Why?
| | Hemoglobinopathies | 1 | 2021 | 5 | 0.040 |
Why?
| | Epilepsy, Absence | 1 | 2020 | 9 | 0.040 |
Why?
| | Age of Onset | 1 | 2022 | 536 | 0.040 |
Why?
| | Epilepsy, Generalized | 1 | 2020 | 19 | 0.040 |
Why?
| | Genome, Bacterial | 1 | 2002 | 151 | 0.040 |
Why?
| | Positive Transcriptional Elongation Factor B | 1 | 2020 | 29 | 0.040 |
Why?
| | Gibberellins | 1 | 2020 | 1 | 0.040 |
Why?
| | Internet | 1 | 2025 | 683 | 0.040 |
Why?
| | Pharmacogenomic Testing | 1 | 2020 | 60 | 0.040 |
Why?
| | Plant Breeding | 1 | 2020 | 20 | 0.040 |
Why?
| | Gene Frequency | 1 | 2021 | 488 | 0.040 |
Why?
| | Plant Proteins | 1 | 2020 | 111 | 0.040 |
Why?
| | Molecular Conformation | 1 | 2019 | 147 | 0.040 |
Why?
| | Color | 1 | 2019 | 81 | 0.040 |
Why?
| | Fluorescence | 1 | 2019 | 161 | 0.040 |
Why?
| | Enzyme Stability | 1 | 2018 | 71 | 0.040 |
Why?
| | Autoimmunity | 1 | 2024 | 908 | 0.040 |
Why?
| | Reproducibility of Results | 2 | 2018 | 3345 | 0.040 |
Why?
| | Amino Acid Substitution | 1 | 2019 | 308 | 0.040 |
Why?
| | Protein Multimerization | 1 | 2019 | 194 | 0.040 |
Why?
| | Tumor Suppressor Protein p53 | 1 | 2022 | 528 | 0.030 |
Why?
| | Molecular Structure | 1 | 2019 | 501 | 0.030 |
Why?
| | Microscopy, Fluorescence | 1 | 2019 | 415 | 0.030 |
Why?
| | TATA-Binding Protein Associated Factors | 1 | 2017 | 18 | 0.030 |
Why?
| | Genes | 1 | 2018 | 229 | 0.030 |
Why?
| | Transcription Factor TFIID | 1 | 2017 | 21 | 0.030 |
Why?
| | Conserved Sequence | 1 | 2018 | 237 | 0.030 |
Why?
| | Magnetic Resonance Spectroscopy | 1 | 2020 | 614 | 0.030 |
Why?
| | RNA, Fungal | 1 | 2017 | 73 | 0.030 |
Why?
| | Seizures | 1 | 2020 | 441 | 0.030 |
Why?
| | Protein Subunits | 1 | 2017 | 228 | 0.030 |
Why?
| | Precision Medicine | 1 | 2020 | 435 | 0.030 |
Why?
| | Inverted Repeat Sequences | 1 | 2016 | 17 | 0.030 |
Why?
| | Regression Analysis | 1 | 2018 | 1013 | 0.030 |
Why?
| | Transcriptome | 1 | 2022 | 1007 | 0.030 |
Why?
| | Chronic Disease | 1 | 2022 | 1807 | 0.030 |
Why?
| | Gene Deletion | 1 | 2017 | 384 | 0.030 |
Why?
| | Dimerization | 1 | 2016 | 196 | 0.030 |
Why?
| | Hypoxia | 1 | 2022 | 1163 | 0.030 |
Why?
| | Survival Analysis | 1 | 2018 | 1322 | 0.030 |
Why?
| | Amino Acids | 1 | 2018 | 491 | 0.030 |
Why?
| | Mice, Inbred C57BL | 1 | 2024 | 5866 | 0.030 |
Why?
| | Molecular Sequence Data | 2 | 2011 | 2911 | 0.020 |
Why?
| | Cytoplasm | 1 | 2014 | 267 | 0.020 |
Why?
| | Transgenes | 1 | 2014 | 185 | 0.020 |
Why?
| | Estrogens | 1 | 2016 | 371 | 0.020 |
Why?
| | Mass Spectrometry | 1 | 2016 | 734 | 0.020 |
Why?
| | Phosphatidylcholines | 1 | 2013 | 131 | 0.020 |
Why?
| | RNA Interference | 1 | 2014 | 465 | 0.020 |
Why?
| | INDEL Mutation | 1 | 2011 | 17 | 0.020 |
Why?
| | Disease Resistance | 1 | 2011 | 27 | 0.020 |
Why?
| | Breeding | 1 | 2011 | 65 | 0.020 |
Why?
| | Nucleic Acid Conformation | 1 | 2014 | 725 | 0.020 |
Why?
| | Peptides | 1 | 2016 | 971 | 0.020 |
Why?
| | Brain | 1 | 2022 | 2857 | 0.020 |
Why?
| | Time Factors | 1 | 2020 | 6951 | 0.020 |
Why?
| | RNA, Messenger | 1 | 2017 | 2815 | 0.020 |
Why?
| | Cell Death | 1 | 2010 | 386 | 0.020 |
Why?
| | Rats | 1 | 2016 | 5556 | 0.020 |
Why?
| | RNA | 1 | 2014 | 927 | 0.020 |
Why?
| | Genotype | 1 | 2011 | 1854 | 0.020 |
Why?
| | Calcium | 1 | 2010 | 1175 | 0.010 |
Why?
| | Histamine | 1 | 2002 | 53 | 0.010 |
Why?
| | Middle Aged | 1 | 2025 | 34658 | 0.010 |
Why?
| | Life Cycle Stages | 1 | 2002 | 39 | 0.010 |
Why?
| | Cross Reactions | 1 | 2002 | 132 | 0.010 |
Why?
| | Aged | 1 | 2022 | 24836 | 0.010 |
Why?
| | Sequence Alignment | 1 | 2002 | 363 | 0.010 |
Why?
| | Cloning, Molecular | 1 | 2002 | 531 | 0.010 |
Why?
| | Blotting, Western | 1 | 2002 | 1220 | 0.010 |
Why?
| | Male | 1 | 2025 | 70140 | 0.010 |
Why?
|
|
Ramachandran's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|